CompletedNot Applicable

Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1

United States200 participantsStarted 2005-09

Plain-language summary

Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer. Each puff of a cigarette delivers a mixture of over 60 known carcinogens. Biomarkers that quantify carcinogen levels and metabolism are a useful tool and available to use. The purpose of this study is to assess the link between tobacco smoke carcinogen biomarkers and the risk of developing lung cancer.

Who can participate

Age range55 Years – 74 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Screening arm participants in the Prostate, Lung, Colon, and Ovarian Screen Trial (PLCO) * Reported smoking on baseline questionnaire of PLCO * Contributed biorepository samples Exclusion Criteria: * Unstable physical or mental health

What they're measuring

Lung cancer

Timeframe: Cumulative incidence

Trial details

NCT IDNCT00218179

SponsorUniversity of Minnesota

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2007-12

View on ClinicalTrials.gov More Tobacco Use Disorder trials